DTL
SGYP

Dynamic Technology Lab’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Dynamic Technology Lab’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-22,684
Closed -$101K – 1531
2017
Q2 		$101K Buy
+22,684
New +$93.5K 0.02% 943
2016
Q2 		– Sell
-17,300
Closed -$48K – 1308
2016
Q1 		$48K Buy
+17,300
New +$62.7K 0.01% 871
2015
Q1 		– Sell
-19,284
Closed -$59K – 979
2014
Q4 		$59K Buy
+19,284
New +$57K 0.03% 607
2013
Q3 		– Sell
-29,531
Closed -$126K – 652
2013
Q2 		$126K Buy
+29,531
New +$148K 0.13% 316

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dynamic Technology Lab's SGYP Position: Q3 2017 in Review

Dynamic Technology Lab sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2017, closing a stake of 22,684 shares — an estimated $101K sold.

Dynamic Technology Lab first reported a position in SGYP in Q2 2013 and held it in 4 quarters. The position peaked at $126K in Q2 2013. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

  • Dynamic Technology Lab reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2017 after selling out during the quarter.
  • Dynamic Technology Lab sold 22,684 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $101K.
  • Dynamic Technology Lab first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 4 quarters.
  • Dynamic Technology Lab's Synergy Pharmaceuticals, Inc Common Stock position peaked at $126K in Q2 2013.
  • 143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Dynamic Technology Lab's 13F filing for Q3 2017, filed 8 Nov 2017.